Does dapagliflozin affect the metabolic response in patients with elevated alanine aminotransferase and Type 2 diabetes? The Association of British Clinical Diabetologists (ABCD) nationwide dapagliflozin audit

被引：0
|
作者：
Yadagiri, M. [1 ]
Sen Gupta, P. [1 ]
Stephens, J. W. [2 ]
Robinson, A. [3 ]
Phylactou, M. [4 ]
Kennedy, A. [5 ]
Clark, J. [6 ]
Wilding, J. [7 ]
Adamson, K. A. [8 ]
Ryder, R. E. J. [1 ]
机构：
[1] Sandwell & West Birmingham Hosp NHS Trust, Dept Diabet, Birmingham, W Midlands, England
[2] Abertawe Bro Morgannwg Univ NHS Trust, Dept Diabet, Swansea, W Glam, Wales
[3] Royal United Hosp Bath NHS Trust, Dept Diabet, Bath, Avon, England
[4] Queen Elizabeth II Hosp, Dept Diabet, Welwyn Garden City, Herts, England
[5] Northern Trust, Antrim Area Hosp, Dept Diabet, Coleraine, Antrim, North Ireland
[6] Surrey & Sussex Healthcare NHS Trust, Dept Diabet, Redhill, Surrey, England
[7] Aintree Univ Hosp NHS Fdn Trust, Dept Diabet, Liverpool, Merseyside, England
[8] West Lothian NHS Trust, Dept Diabet, Livingston, Scotland
来源：
DIABETIC MEDICINE | 2016年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A73
引用
收藏
页码：30 / 31
页数：3
相关论文
共 41 条
  • [21] Dapagliflozin Does Not Affect Short-Term Blood Pressure Variability in Patients With Type 2 Diabetes Mellitus
    Papadopoulou, Eirini
    Theodorakopoulou, Marieta P.
    Loutradis, Charalampos
    Tzanis, Georgios
    Tzatzagou, Glykeria
    Kotsa, Kalliopi
    Zografou, Ioanna
    Tsapas, Apostolos
    Karagiannis, Asterios
    Sarafidis, Pantelis
    AMERICAN JOURNAL OF HYPERTENSION, 2021, 34 (04) : 404 - 413
  • [22] RISK FACTORS FOR DIABETES-RELATED DISTRESS IN PEOPLE LIVING WITH TYPE 1 DIABETES - LESSONS FROM THE ASSOCIATION OF BRITISH CLINICAL DIABETOLOGISTS (ABCD) FREESTYLE LIBRE AUDIT
    Wilmot, E.
    Deshmukh, H.
    Kilvert, A.
    Barnes, D.
    Herring, R.
    Banatwalla, R.
    Narendran, P.
    Patmore, J.
    Walton, C.
    Sathyapalan, T.
    Ryder, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A59 - A60
  • [23] The impact of sodium glucose link transporter-2 inhibitors (SGLT2i) on Fib4 score in patients with type 2 diabetes: Analysis using Association of British Clinical Diabetologists (ABCD) nationwide audit data
    Crabtree, T. S. J.
    Elliott, J.
    Sivappriyan, S.
    Barnes, D.
    Bickerton, A.
    Gallen, I.
    Idris, I.
    Ryder, R. E. J.
    DIABETIC MEDICINE, 2021, 38
  • [24] Effectiveness of canagliflozin in a real-life clinical setting in Northern Ireland: Combining data from the Association Of British Clinical Diabetologists (ABCD) nationwide canagliflozin audit and the Diamond Diabetes Database
    Strzelecka, A.
    DIABETIC MEDICINE, 2020, 37 : 64 - 64
  • [25] The effect of dapagliflozin on HbA1c and weight after its addition to commonly prescribed dual combination diabetes medication regimens in people with Type 2 diabetes in a real-world UK setting: the ABCD nationwide dapagliflozin audit
    Yadagiri, M.
    Gupta, P. S.
    Kennnedy, A.
    Pang, T.
    Balmuri, L.
    Robinson, T.
    Bain, S.
    Gallen, I. W.
    Adamson, K.
    Ryder, R. E. J.
    DIABETIC MEDICINE, 2017, 34 : 192 - 192
  • [26] One year results of Association of British Clinical Diabetologists (ABCD) EndoBarrier in Type 2 diabetes/prediabetes with obstructive sleep apnoea study
    Yadagiri, M.
    Kinney, F.
    Adams, J.
    Mohammed, A.
    Bleasdale, J. P.
    Fogden, E. N.
    Anderson, M. R.
    Greenstone, M.
    Walton, C.
    Ryder, R. E. J.
    DIABETIC MEDICINE, 2019, 36 : 146 - 147
  • [27] Use of Insulin Degludec in Type 1 Diabetes Clinical Practice in the UK-General Practice Data from Two English Regions and Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Degludec Audit
    Lumb, Alistair N.
    Gallen, Ian W.
    Bickerton, Alex
    Abraham, Ralph R.
    Bain, Stephen C.
    Harper, Roy
    Ryder, Robert E.
    DIABETES, 2018, 67
  • [28] Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study
    Mor, Anil
    Svensson, Elisabeth
    Rungby, Jorgen
    Ulrichsen, Sinna Pilgaard
    Berencsi, Klara
    Nielsen, Jens Steen
    Stidsen, Jacob Volmer
    Friborg, Soren
    Brandslund, Ivan
    Christiansen, Jens Sandahl
    Beck-Nielsen, Henning
    Sorensen, Henrik Toft
    Thomsen, Reimar Wernich
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (08) : 707 - 715
  • [29] Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in type 1 diabetes
    Dashora, Umesh
    Patel, Dipesh
    Gregory, Rob
    Nagi, Dinesh
    BRITISH JOURNAL OF DIABETES, 2018, 18 (03): : 117 - 121
  • [30] Effect of Raised Alanine Transaminase (ALT) Levels on HbA1c in the Association of British Clinical Diabetologists (ABCD) Nationwide Audits of SGLT2 Inhibitors (SGLT2i)
    Deshmukh, Harshal
    Bickerton, Alex
    Phillips, Suzanne M.
    Evans, Alison
    Raghavan, Rajeev P.
    Sennik, Devesh K.
    Rohilla, Anurita
    Adamson, Karen
    Yadagiri, Mahender
    Gallen, Ian W.
    Ryder, Robert E.
    Sathyapalan, Thozhukat
    DIABETES, 2020, 69
12345